The pharmaceutical and biotechnical research demands for high-purity chemicals, solvents, buffers and reference substances is enormous. A recognized leader in the development, manufacture and distribution of the needed materials is headquartered in St. Louis, Missouri.
Sigma-Aldrich Corporation's (NASDAQ:SIAL) biochemical and organic products are used in genomic research, biotechnology processes, pharmaceutical endeavors and the diagnosis of diseases. Its fine chemicals units provide materials for commercial manufacturing applications. Customers are life science firms, universities, government institutions, industrial concerns and hospitals. The company employs over 6,800 and operates in 35 countries.
The firm pleased investors last month, when it reported Q4 EPS of 51 cents (ex-items) and revenues of $464.5 million.
Analysts had been expecting 47 cents and $447.7 million. Management also guided FY07 EPS to $2.15-$2.25, versus $2.15 consensus. The CEO cited expected organic sales growth, contributions from the recently acquired Epichem Group and favorable currency exchange rates in support of the positive outlook. The news popped the shares out of a February "cup" into the March "handle" of a Cup & Handle formation. The price is now showing signs of completing the pattern with a bullish rise from the right-hand side of the "handle".
Brokers recommend the issue with two "strong buys", one "buy" and six "holds". The stock's ratios compare favorably with industry, sector and S&P 500 averages: P/E ratio - 19.96, Price to Book ratio - 3.83, Price to Free Cash Flow ratio - 27.03, Sales Growth rate - 13.15%, Operating Margin - 21.07%, Net Profit Margin - 15.40%, Return on Assets - 12.40%, Return on Investment - 15.54% and Return on Equity - 20.94%.
Institutional investors hold about 85% of the outstanding shares. The stock is one of those used to calculate the S&P 500 Index. Over the past 52 weeks, it has traded between $31.79 and $42.91. A stop-loss of $35.60 looks good here.
Larry Schutts is a contributing editor for Theflyonthewall.com and the Vice-President of Stockwinners.com.
Closing Bell: Dubai sends jitters throughout the market (S, BBY)
Heinz looking good after the second quarter?
Why isn't Bank of America updating its shareholders on CEO situation?
